Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway (Q39852417)

15 September 2017

Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway (English)

1 reference

15 September 2017

1 reference

Azusa Matsumoto

1

1 reference

15 September 2017

Tatsuki Ichikawa

2

1 reference

15 September 2017

Kazuhiko Nakao

3

1 reference

15 September 2017

Hisamitsu Miyaaki

4

1 reference

15 September 2017

Kumi Hirano

5

1 reference

15 September 2017

Masumi Fujimito

6

1 reference

15 September 2017

Motohisa Akiyama

7

1 reference

15 September 2017

Satoshi Miuma

8

1 reference

15 September 2017

Eisuke Ozawa

9

1 reference

15 September 2017

Hidetaka Shibata

10

1 reference

15 September 2017

Shigeyuki Takeshita

11

1 reference

15 September 2017

Hironori Yamasaki

12

1 reference

15 September 2017

Masanori Ikeda

13

1 reference

15 September 2017

Nobuyuki Kato

14

1 reference

15 September 2017

Katsumi Eguchi

15

1 reference

15 September 2017

13 May 2009

1 reference

Journal of Gastroenterology

15 September 2017

1 reference

15 September 2017

44

1 reference

15 September 2017

8

1 reference

15 September 2017

856-863

1 reference

Structure, regulation and function of PKB/AKT--a major therapeutic target

15 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-009-0075-1

The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00535-009-0075-1

Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells

21 January 2018

1 reference

12 December 2020

p21-activated kinase 1 is activated through the mammalian target of rapamycin/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells

1 reference

12 December 2020

HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines

1 reference

12 December 2020

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

1 reference

12 December 2020

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

1 reference

12 December 2020

Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.

1 reference

12 December 2020

Roles of phosphatidylinositol 3-kinase in interferon-gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression

1 reference

12 December 2020

Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

1 reference

12 December 2020

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

1 reference

12 December 2020

Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway

1 reference

12 December 2020

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

1 reference

12 December 2020

Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment

1 reference

12 December 2020

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

1 reference

12 December 2020

The PI3' kinase pathway in interferon signaling.

1 reference

12 December 2020

Suppression of viral replication by stress-inducible GADD34 protein via the mammalian serine/threonine protein kinase mTOR pathway

1 reference

12 December 2020

Regulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction Pathway

1 reference

12 December 2020

AMPK-mediated inhibition of mTOR kinase is circumvented during immediate-early times of human cytomegalovirus infection

1 reference

12 December 2020

mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes

1 reference

12 December 2020

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy

1 reference

12 December 2020

p48 Overexpression enhances interferon-mediated expression and activity of double-stranded RNA-dependent protein kinase in human hepatoma cells

1 reference

12 December 2020

Differential regulation of the p70 S6 kinase pathway by interferon alpha (IFNalpha) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells

1 reference

12 December 2020

Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication

1 reference

12 December 2020

Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.

1 reference

12 December 2020

Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cells

1 reference

12 December 2020

mTOR, translation initiation and cancer

1 reference

12 December 2020

Complex modulation of cell type-specific signaling in response to type I interferons

1 reference

12 December 2020

Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells

1 reference

12 December 2020

DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.

1 reference

12 December 2020

Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus

1 reference

12 December 2020

Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy

1 reference

12 December 2020

The hepatitis C virus life cycle as a target for new antiviral therapies

1 reference

12 December 2020

10.1007/S00535-009-0075-1

Identifiers

DOI

1 reference

15 September 2017

1 reference